Gastroenterology
Volume 137, Issue 5 , Pages 1785-1794 , November 2009

Transmembrane and Soluble Isoforms of Heparin-Binding Epidermal Growth Factor–Like Growth Factor Regulate Distinct Processes in the Pancreas

  • Kevin C. Ray

      Affiliations

    • Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
    • ,
  • Stacy A. Blaine

      Affiliations

    • Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
    • ,
  • M. Kay Washington

      Affiliations

    • Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee
    • ,
  • Ada H. Braun

      Affiliations

    • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
    • Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee
    • ,
  • Amar B. Singh

      Affiliations

    • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
    • ,
  • Raymond C. Harris

      Affiliations

    • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
    • Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee
    • ,
  • Paul A. Harding

      Affiliations

    • Department of Zoology, Miami University, Oxford, Ohio
    • ,
  • Robert J. Coffey

      Affiliations

    • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
    • Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee
    • ,
  • Anna L. Means

      Affiliations

    • Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
    • Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee
    • Corresponding Author InformationReprint requests Address requests for reprints to: Anna L. Means, PhD, Division of Surgical Oncology, Vanderbilt University Medical Center, 10445 MRB IV, 2213 Garland Avenue, Nashville, Tennessee 37232-0443. fax: (615)-343-1591

Received 5 December 2008 ,Accepted 31 July 2009.

References 

  1. Kaneto H, Miyagawa J, Kajimoto Y, et al. Expression of heparin-binding epidermal growth factor-like growth factor during pancreas development (A potential role of PDX-1 in transcriptional activation). J Biol Chem. 1997;272:29137–29143
  2. Miyagawa J, Hanafusa O, Sasada R, et al. Immunohistochemical localization of betacellulin, a new member of the EGF family, in normal human pancreas and islet tumor cells. Endocr J. 1999;46:755–764
  3. Miettinen PJ, Ustinov J, Ormio P, et al. Downregulation of EGF receptor signaling in pancreatic islets causes diabetes due to impaired postnatal beta-cell growth. Diabetes. 2006;55:3299–3308
  4. Bockman DE, Merlino G. Cytological changes in the pancreas of transgenic mice overexpressing transforming growth factor alpha. Gastroenterology. 1992;103:1883–1892
  5. Sandgren EP, Luetteke NC, Palmiter RD, et al. Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell. 1990;61:1121–1135
  6. Prenzel N, Zwick E, Daub H, et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 1999;402:884–888
  7. Uchiyama-Tanaka Y, Matsubara H, Mori Y, et al. Involvement of HB-EGF and EGF receptor transactivation in TGF-beta-mediated fibronectin expression in mesangial cells. Kidney Int. 2002;62:799–808
  8. Higashiyama S, Iwamoto R, Goishi K, et al. The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J Cell Biol. 1995;128:929–938
  9. Iwamoto R, Handa K, Mekada E. Contact-dependent growth inhibition and apoptosis of epidermal growth factor (EGF) receptor-expressing cells by the membrane-anchored form of heparin-binding EGF-like growth factor. J Biol Chem. 1999;274:25906–25912
  10. Nakamura K, Iwamoto R, Mekada E. Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites. J Cell Biol. 1995;129:1691–1705
  11. Singh AB, Tsukada T, Zent R, et al. Membrane-associated HB-EGF modulates HGF-induced cellular responses in MDCK cells. J Cell Sci. 2004;117:1365–1379
  12. Wang F, Sloss C, Zhang X, et al. Membrane-bound heparin-binding epidermal growth factor like growth factor regulates E-cadherin expression in pancreatic carcinoma cells. Cancer Res. 2007;67:8486–8493
  13. Yamazaki S, Iwamoto R, Saeki K, et al. Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities. J Cell Biol. 2003;163:469–475
  14. Means AL, Ray KC, Singh AB, et al. Overexpression of heparin-binding EGF-like growth factor in mouse pancreas results in fibrosis and epithelial metaplasia. Gastroenterology. 2003;124:1020–1036
  15. Gannon M, Gamer LW, Wright CV. Regulatory regions driving developmental and tissue-specific expression of the essential pancreatic gene pdx1. Dev Biol. 2001;238:185–201
  16. Louet JF, LeMay C, Mauvais-Jarvis F. Antidiabetic actions of estrogen: insight from human and genetic mouse models. Curr Atheroscler Rep. 2004;6:180–185
  17. Means AL, Meszoely IM, Suzuki K, et al. Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates. Development. 2005;132:3767–3776
  18. Jaster R. Molecular regulation of pancreatic stellate cell function. Mol Cancer. 2004;3:26
  19. Wagner M, Luhrs H, Kloppel G, et al. Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice. Gastroenterology. 1998;115:1254–1262
  20. Wagner M, Weber CK, Bressau F, et al. Transgenic overexpression of amphiregulin induces a mitogenic response selectively in pancreatic duct cells. Gastroenterology. 2002;122:1898–1912
  21. Krakowski ML, Kritzik MR, Jones EM, et al. Transgenic expression of epidermal growth factor and keratinocyte growth factor in beta-cells results in substantial morphological changes. J Endocrinol. 1999;162:167–175
  22. Siveke JT, Einwachter H, Sipos B, et al. Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN. Cancer Cell. 2007;12:266–279
  23. Grippo PJ, Nowlin PS, Demeure MJ, et al. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice. Cancer Res. 2003;63:2016–2019
  24. Guillam MT, Hummler E, Schaerer E, et al. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. Nat Genet. 1997;17:327–330
  25. Thorens B, Guillam MT, Beermann F, et al. Transgenic reexpression of GLUT1 or GLUT2 in pancreatic beta cells rescues GLUT2-null mice from early death and restores normal glucose-stimulated insulin secretion. J Biol Chem. 2000;275:23751–23758

 Conflicts of interest The authors disclose no conflicts.

 Funding This work was supported by National Institutes of Health grants CA98322 (A.L.M.), CA84239 (R.J.C. and A.L.M.), CA95103 (R.J.C.), CA46413 (R.J.C.), and DK58404 (M.K.W.) and with the support of the Vanderbilt ES/Transgenic Core, Vanderbilt Hormone Assay Core, and the Vanderbilt Cell Imaging Shared Resource.

PII: S0016-5085(09)01399-7

doi: 10.1053/j.gastro.2009.07.067

Gastroenterology
Volume 137, Issue 5 , Pages 1785-1794 , November 2009

Article Tools

* Image Usage & Resolution